Developing nanobodies as allosteric molecular chaperones of glucocerebrosidase function
Thomas Dal Maso(Vrije Universiteit Brussel), Nicoletta Plotegher(University of Padua)
Cited by 3
Related Papers
LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease
|npj Parkinson s Disease|2022|45
Impaired cellular bioenergetics caused by GBA1 depletion sensitizes neurons to calcium overload
|Cell Death and Differentiation|2019|41
The activities of LRRK2 and GCase are positively correlated in clinical biospecimens and experimental models of Parkinson’s disease
|bioRxiv (Cold Spring Harbor Laboratory)|2021|2
Identification and characterization of nanobodies acting as molecular chaperones for glucocerebrosidase through a novel allosteric mechanism
|bioRxiv (Cold Spring Harbor Laboratory)|2024|2